S SCITARIS BIOPHARMA STRATEGY
Live / Registered — Registered (as of 02 Aug 2022)
What this means for you
Registered since 02 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79330088
- Registration number
- 6805709
- Mark type
- Design + words
- Filed
- 05 Jul 2021
- Published for opposition
- 17 May 2022
- Registered
- 02 Aug 2022
- Attorney of record
- Frank D Taff
Goods and services
- Class 035 — Advertising and business services: Advertising; business management; business administration
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of pharmaceuticals; medical device design services; product development; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; medical and pharmacological research services; quality control for others in the field of pharmaeeuticals; authentication services being inspection of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: Medical services; pharmacy advice; medical consultancy and information services relating to medical products
Owner
- Scitaris GmbH, DE
- Scitaris GmbH, DE
- Scitaris GmbH, DE
Prosecution history
- 12 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Dec 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 Nov 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 Nov 2022 — FINAL DISPOSITION PROCESSED
- 02 Nov 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 17 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 May 2022 — PUBLISHED FOR OPPOSITION
- 16 May 2022 — NOTIFICATION PROCESSED BY IB
- 27 Apr 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Apr 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 27 Apr 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Apr 2022 — REFUSAL PROCESSED BY IB
- 14 Apr 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER